"","submission_name","submission_date","template_name","tissue_type","response_component_original","response_comp_orig_cnt","response_component","response_comp_cnt","cell_ontology_id","proterm_and_extra","pro_ontology_id","fully_qualified_response_component","response_behavior_type","response_behavior","subgroup","time_point","time_point_units","baseline_time","target_pathogen","vaccine_year","additional_exposure_material","comparison","cohort","adjuvant","route","publication_reference","publication_year","signature_source","signature_source_url","comments","publication_reference_url","age_group","age_min","age_max","age_units","subm_obs_id","uniq_obs_id","row_key","signature_file","exposure_material_1","exposure_material_2"
"subject","","","","cell_subset","","","cell_subset","","","","","","","","","","","","pathogen","","","","","","","","","","","","","","","","","","","","","vaccine","vaccine"
"evidence","","","","","label","label","","label","label","label","label","label","label","label","label","label","label","label","","label","label","label","label","label","label","label","label","label","label","label","url","label","label","label","label","label","label","label","file","",""
"role","","","","tissue","observed","observed","cell_biomarker","observed","observed","observed","observed","observed","background","measured","background","observed","observed","background","pathogen","background","background","background","observed","background","background","background","background","background","background","background","reference","observed","observed","observed","observed","background","background","background","observed","vaccine","vaccine"
"mime_type","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"numeric_units","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"display_text","","","","tissue type","response component (original cell type)","response component (original) count","response component (cell subset)","response component count","cell ontology ID","cell type PRO and extra terms","protein ontology ID","all response components in signature","response behavior type","response behavior","subgroup","time point","time point units","baseline time","target pathogen","vaccine year","exposure material - additional","comparison","cohort","adjuvant","route","publication reference (PMID)","publication year","signature source figure, table or text section","signature source url","comments and additional details","Grode et al. (2013) Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835' target='_blank'>23290835</a>","cohort","age min.","age max.","age units","ID of observation within its own submission","Uniq ID of observation within its submission type","row key","response component (cell types) file","exposure material 1 (VO)","exposure material 2 (VO)"
"","hipc_ctf_23290835_2","2013.02","hipc_ctf_23290835_2","peripheral blood mononuclear cell","triple-positive (interferon-gamma, tumor necrosis factor-alpha, interleukin-2) CD4 T cells","1","CD4-positive, alpha-beta T cell","1","CL_0000624","& IFNG+, TNF-a+, IL-2+","PR:000000017, PR:000000134, PR:000001379","CD4-positive, alpha-beta T cell & IFNG+, TNF-a+, IL-2+","cell type frequency","up","none","29","Days","time of vaccination (first dose)","mycobacterium tuberculosis variant bovis BCG","","","VPM1002-3 vs BCG vaccine","adults (18-55)","","","23290835","2013","Fig 3B","<a href = 'https://www.sciencedirect.com/science/article/pii/S0264410X12018403?via%3Dihub#fig0015' target='_blank'>S0264410X12018403?via%3Dihub#fig0015</a>","","https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835","adults","18","55","years","2","42","23290835_2_42","hipc_ctf_sig_23290835_2.txt","VO_0000771","VO_0003131"
